These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 20451571
21. In vivo characterization of the effects of human hemokinin-1 and human hemokinin-1(4-11), mammalian tachykinin peptides, on the modulation of pain in mice. Fu CY, Zhao YL, Dong L, Chen Q, Ni JM, Wang R. Brain Behav Immun; 2008 Aug; 22(6):850-60. PubMed ID: 18262387 [Abstract] [Full Text] [Related]
22. Effects of rat/mouse hemokinin-1, a mammalian tachykinin peptide, on the antinociceptive activity of pethidine administered at the peripheral and supraspinal level. Fu CY, Tang XL, Yang Q, Chen Q, Wang R. Behav Brain Res; 2007 Nov 22; 184(1):39-46. PubMed ID: 17675256 [Abstract] [Full Text] [Related]
23. How important are NK1 receptors for influencing microvascular inflammation and itch in the skin? Studies using Phoneutria nigriventer venom. Costa SK, Starr A, Hyslop S, Gilmore D, Brain SD. Vascul Pharmacol; 2006 Oct 22; 45(4):209-14. PubMed ID: 16914387 [Abstract] [Full Text] [Related]
24. Nociceptin-induced scratching, biting and licking in mice: involvement of spinal NK1 receptors. Sakurada T, Katsuyama S, Sakurada S, Inoue M, Tan-No K, Kisara K, Sakurada C, Ueda H, Sasaki J. Br J Pharmacol; 1999 Aug 22; 127(7):1712-8. PubMed ID: 10455330 [Abstract] [Full Text] [Related]
25. S-(+)-fenfluramine-induced nociceptive behavior in mice: Involvement of interactions between spinal serotonin and substance P systems. Tan-No K, Takahashi K, Shimoda M, Sugawara M, Nakagawasai O, Niijima F, Sato T, Satoh S, Tadano T. Neuropeptides; 2007 Feb 22; 41(1):33-8. PubMed ID: 17140659 [Abstract] [Full Text] [Related]
26. Intrathecal histamine induces spinally mediated behavioral responses through tachykinin NK1 receptors. Sakurada S, Orito T, Furuta S, Watanabe H, Mobarakeh JI, Yanai K, Watanabe T, Sato T, Onodera K, Sakurada C, Sakurada T. Pharmacol Biochem Behav; 2003 Jan 22; 74(2):487-93. PubMed ID: 12479971 [Abstract] [Full Text] [Related]
27. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments. Komatsu T, Sasaki M, Sanai K, Kuwahata H, Sakurada C, Tsuzuki M, Iwata Y, Sakurada S, Sakurada T. Peptides; 2009 Sep 22; 30(9):1689-96. PubMed ID: 19520130 [Abstract] [Full Text] [Related]
28. Functional characterisation of hemokinin-1 in mouse uterus. Patak E, Pennefather JN, Gozali M, Candenas L, Kerr K, Exintaris B, Ziccone S, Potteck H, Chetty N, Page NM, Pinto F. Eur J Pharmacol; 2008 Dec 28; 601(1-3):148-53. PubMed ID: 18977217 [Abstract] [Full Text] [Related]
29. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils. Nordquist RE, Durkin S, Jacquet A, Spooren W. Eur J Pharmacol; 2008 Dec 14; 600(1-3):87-92. PubMed ID: 18930726 [Abstract] [Full Text] [Related]
30. Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level. Fu CY, Yang Q, Wang KR, Kong ZQ, Chen Q, Wang R. Behav Brain Res; 2006 Jun 30; 170(2):293-301. PubMed ID: 16621052 [Abstract] [Full Text] [Related]
31. Morphine (intracerebroventricular) activates spinal systems to inhibit behavior induced by putative pain neurotransmitters. DeLander GE, Wahl JJ. J Pharmacol Exp Ther; 1989 Dec 30; 251(3):1090-5. PubMed ID: 2481030 [Abstract] [Full Text] [Related]
32. Cardiovascular responses to rat/mouse hemokinin-1, a mammalian tachykinin peptide: systemic study in anesthetized rats. Fu CY, Kong ZQ, Long Y, Chen Q, Wang R. Eur J Pharmacol; 2007 Oct 31; 572(2-3):175-81. PubMed ID: 17628523 [Abstract] [Full Text] [Related]
33. [Intrathecal injection of Sar9, Met(O2)11-substance P, neurokinin-1 receptor agonist, increases nitric oxide synthase expression and nitric oxide production in the rat spinal cord]. Sun XC, Li WB, Li SQ, Li QJ, Chen XL, Ai J. Sheng Li Xue Bao; 2003 Dec 25; 55(6):677-83. PubMed ID: 14695485 [Abstract] [Full Text] [Related]
35. The common carboxyl-terminal region of novel tachykinin peptides contributes to induce desensitization in scratching behavior of rats. Naono R, Yoshioka D, Ikeda T, Nakayama T, Nishimori T. Brain Res Bull; 2007 Mar 15; 71(5):461-5. PubMed ID: 17259014 [Abstract] [Full Text] [Related]
36. Intrathecally administered D-cycloserine produces nociceptive behavior through the activation of N-methyl-D-aspartate receptor ion-channel complex acting on the glycine recognition site. Tan-No K, Esashi A, Nakagawasai O, Niijima F, Furuta S, Sato T, Satoh S, Yasuhara H, Tadano T. J Pharmacol Sci; 2007 May 15; 104(1):39-45. PubMed ID: 17452810 [Abstract] [Full Text] [Related]
37. Behavior induced by putative nociceptive neurotransmitters is inhibited by adenosine or adenosine analogs coadministered intrathecally. DeLander GE, Wahl JJ. J Pharmacol Exp Ther; 1988 Aug 15; 246(2):565-70. PubMed ID: 2457077 [Abstract] [Full Text] [Related]
38. Intrathecal administration of the common carboxyl-terminal decapeptide in endokinin A and endokinin B evokes scratching behavior and thermal hyperalgesia in the rat. Yoshioka D, Takebuchi F, Nishimori T, Naono R, Ikeda T, Nakayama T. Neurosci Lett; 2006 Dec 27; 410(3):193-7. PubMed ID: 17101218 [Abstract] [Full Text] [Related]
39. Spinally-mediated behavioural responses evoked by intrathecal high-dose morphine: possible involvement of substance P in the mouse spinal cord. Sakurada T, Wako K, Sakurada C, Manome Y, Tan-no K, Sakurada S, Kisara K. Brain Res; 1996 Jun 17; 724(2):213-21. PubMed ID: 8828571 [Abstract] [Full Text] [Related]